CorMedix

CRMD65

$7.01arrow_drop_down3.31%-$0.24

CRMD65

$7.01

arrow_drop_down3.31%-$0.24

Performance History

Key Stats
Open	$7.40
Prev. Close	$7.25
EPS	-0.92
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	6.85	7.56
52 Week Range	2.57	7.56

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.92

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About CorMedix (CRMD)

CorMedix Inc (CRMD) is a pharmaceutical company that specializes in the development and commercialization of therapeutic drugs for the prevention and treatment of infectious and inflammatory diseases. The company is focused on addressing unmet medical needs through its innovative products. With a strong commitment to research and development, CorMedix is dedicated to improving patient outcomes and overall healthcare.

As of [DATE], the stock price of CorMedix Inc (CRMD) stands at [PRICE]. The company has experienced fluctuations in its stock price, influenced by various factors such as market conditions, industry trends, and company performance. Investors should carefully analyze the stock's history and consider factors that may impact its future value before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Joseph Todisco MBA
Headquarters: Berkeley Heights
Employees: 40
Exchange: NASDAQ

Keep an eye on CorMedix

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is CorMedix 's (CRMD) price per share?

The current price per share for CorMedix (CRMD) is $7.01. The stock has seen a price change of -$0.24 recently, indicating a -3.31% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for CorMedix (CRMD)?

For CorMedix (CRMD), the 52-week high is $7.56, which is 7.85% from the current price. The 52-week low is $2.57, the current price is 172.76% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is CorMedix (CRMD) a growth stock?

CorMedix (CRMD) has shown an average price growth of 0.41% over the past three years. It has received a score of 41 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying CorMedix as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is CorMedix (CRMD) stock price performance year to date (YTD)?

As of the latest data, CorMedix (CRMD) has a year-to-date price change of 85.94%. Over the past month, the stock has experienced a price change of 35.85%. Over the last three months, the change has been 58.24%. Over the past six months, the figure is 83.03%. Looking at a longer horizon, the five-year price change stands at -16.35%.

help

Is CorMedix (CRMD) a profitable company?

CorMedix (CRMD) has a net income of -$46.34M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.9K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$48.96M. Furthermore, the EBITDA is -$58.01M.

help

What is the market capitalization of CorMedix (CRMD)?

CorMedix (CRMD) has a market capitalization of $404.71M. The average daily trading volume is 1.15M, indicating the stock's liquidity and investor engagement.